# GLYCOPYRROLATE
> **ANDA216297** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-10-07
## Drug
- **FDA Application Number:** ANDA216297
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLYCOPYRROLATE
- **Generic name:** GLYCOPYRROLATE
- **Active ingredients:** GLYCOPYRROLATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Saptalis Pharmaceuticals, LLC.
- **First approval:** 2024-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216297)
---
*AI Analytics · CC0 1.0*